Pronóstico del mercado de microportadores de América del Sur y Central hasta 2030 – Análisis regional – por producto (medios, reactivos y perlas de microportadores), equipo (biorreactores, recipientes de cultivo y otros), aplicación (producción biofarmacéutica, terapia celular y genética, ingeniería de tejidos y medicina regenerativa) , y otros), y usuario final (empresas farmacéuticas y de biotecnología, organizaciones de investigación por contrato y organizaciones de fabricación por contrato, e institutos académicos y de investigación)

BMIRE00029980 | Pages: 77 | Biotechnology | Apr 2024 | Type: Regional | Status: Published
Se espera que el mercado de microportadores de América del Sur y Central crezca de 68,77 millones de dólares en 2022 a 129,96 millones de dólares en 2030. Se estima que registrará una tasa compuesta anual del 8,3% entre 2022 y 2030. Impulsa la automatización de los servicios de fabricación de terapias celulares y génicas Mercado de microportadores de América del Sur y Central La incorporación de la automatización en la fabricación de terapias celulares y génicas conduciría a un riesgo reducido de contaminación, una mayor consistencia y una disminución del costo de producción. Lonza Cocoon y el sistema CliniMACS Prodigy de Miltenyi son algunos de los dispositivos disponibles en el mercado que han sido diseñados para permitir la automatización de la mayoría de las operaciones unitarias secuenciales para un proceso CAR-T dentro de un solo sistema. La creciente demanda de terapias celulares y genéticas ha desplazado la producción de un proceso de pequeño volumen a un proceso de gran volumen en todo el mundo. El progreso de la terapia celular y genética desde un entorno académico y clínico hasta la producción y comercialización en masa impulsa aún más la demanda de automatización en la fabricación comercial. Así, la automatización se perfila como una nueva tendencia en el mercado de los microportadores. Descripción general del mercado de microportadores de América del Sur y Central El mercado de microportadores de América del Sur y Central está segmentado en Brasil, Argentina y el resto de América del Sur y Central. Un aumento en diversas actividades de investigación, el aumento del gasto en atención médica, las crecientes inversiones en biotecnología, la creciente incidencia de enfermedades infecciosas y los esfuerzos gubernamentales para promover la utilización de medios de cultivo celular inmovilizados para facilitar los procesos de atención médica son factores importantes que contribuyen al crecimiento del mercado. Según un informe titulado \"Primeros productos de terapia génica aprobados en Brasil\", publicado por Law Business Research 2020, Brasil se encuentra entre los primeros países latinoamericanos en aprobar la comercialización de productos de terapia génica. La Agencia Brasileña de Regulación Sanitaria (ANVISA) ha concedido la autorización de comercialización para los productos de terapia génica de Novartis: Luxturna y Zolgensma. Ambos productos fueron aprobados por la Comisión Técnica Brasileña de Bioseguridad (CTNBio), responsable de evaluar la bioseguridad de los organismos genéticamente modificados en Brasil. En septiembre de 2021, Sorrento Therapeutics comenzó la inscripción de sujetos en el ensayo clínico de fase II de células madre mesenquimales alogénicas derivadas del tejido adiposo humano (COVI-MSC) para el tratamiento de pacientes con COVID-19 con síndrome de dificultad respiratoria aguda (SDRA) o dificultad respiratoria aguda (ARD). en Brasil. Así, estos avances en terapia celular impulsan el crecimiento del mercado de microportadores en Brasil. Ingresos y pronóstico del mercado de microportadores de América del Sur y Central hasta 2030 (millones de dólares estadounidenses) Segmentación del mercado de microportadores de América del Sur y Central El mercado de microportadores de América del Sur y Central está segmentado en producto, equipo, aplicación, usuario final y país. Según el producto, el mercado de microportadores de América del Sur y Central se bifurca en perlas de microportadores y medios y reactivos. El segmento de microportadores de perlas tuvo una mayor participación en el mercado de microportadores de América del Sur y Central en 2022. En términos de equipos, el mercado de microportadores de América del Sur y Central está segmentado en biorreactores, recipientes de cultivo y otros. El segmento de biorreactores tuvo la mayor participación del mercado de microportadores de América del Sur y Central en 2022. Según la aplicación, el mercado de microportadores de América del Sur y Central se segmenta en producción biofarmacéutica, terapia celular y genética, ingeniería de tejidos y medicina regenerativa, entre otros. El segmento de producción biofarmacéutica tuvo la mayor participación del mercado de microportadores de América del Sur y Central en 2022. Además, el segmento de producción biofarmacéutica se clasifica en producción de proteínas terapéuticas y producción de vacunas. Según el usuario final, el mercado de microportadores de América del Norte está segmentado en empresas farmacéuticas y de biotecnología, organizaciones de investigación por contrato y organizaciones de fabricación por contrato, e institutos académicos y de investigación. El segmento de empresas farmacéuticas y de biotecnología tuvo la mayor participación del mercado de microportadores de América del Norte en 2022. Según el país, el mercado de microportadores de América del Sur y Central está segmentado en Brasil, Argentina y el resto de América del Sur y Central. Brasil dominó el mercado de microportadores de América del Sur y Central en 2022. Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp y Polysciences Inc son algunas de las empresas líderes que operan en el mercado de microportadores de América del Sur y Central.
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Microcarriers Market - Key Industry Dynamics

4.1 Key Market Drivers:

4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases

4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing

4.1.3 Surge in Adoption of Regenerative Medicine

4.2 Market Restraints

4.2.1 High Cost of Biologics and Cell-based Therapies

4.3 Market Opportunities

4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers

4.4 Future Trends

4.4.1 Automation of Cell and Gene Therapy Manufacturing Services

4.5 Impact Analysis

5. Microcarriers Market - South & Central America Market Analysis

5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Microcarriers Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Microcarrier Beads

6.3.1 Overview

6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Media and Reagents

6.4.1 Overview

6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

7.1 Overview

7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)

7.3 Bioreactors

7.3.1 Overview

7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Culture Vessels

7.4.1 Overview

7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Microcarriers Market - Revenue and Forecast to 2030 - by Application

8.1 Overview

8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)

8.3 Biopharmaceutical Production

8.3.1 Overview

8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Cell and Gene Therapy

8.4.1 Overview

8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Tissue Engineering and Regenerative Medicine

8.5.1 Overview

8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Microcarriers Market Revenue and Forecasts To 2030 - End User

9.1 Overview

9.2 South & Central America Microcarriers Market Share by End User - 2022 & 2030 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)

9.4 Contract Research Organizations and Contract Manufacturing Organizations

9.4.1 Overview

9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Microcarriers Market Revenue and Forecasts to 2030 -Country Analysis

10.1 South & Central America Microcarriers Market, Revenue and Forecast To 2030

10.1.1 Overview

10.1.2 South & Central America: Microcarriers Market, by Country

10.1.2.1 Brazil

10.1.2.1.1 Overview

10.1.2.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)

10.1.2.1.3 Brazil: Microcarriers Market, by Product

10.1.2.1.4 Brazil: Microcarriers Market, by Equipment

10.1.2.1.5 Brazil: Microcarriers Market, by Application

10.1.2.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production

10.1.2.1.6 Brazil: Microcarriers Market, by End User

10.1.2.2 Argentina

10.1.2.2.1 Overview

10.1.2.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.2.3 Argentina: Microcarriers Market, by Product

10.1.2.2.4 Argentina: Microcarriers Market, by Equipment

10.1.2.2.5 Argentina: Microcarriers Market, by Application

10.1.2.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production

10.1.2.2.6 Argentina: Microcarriers Market, by End User

10.1.2.3 Rest Of South & Central America

10.1.2.3.1 Overview

10.1.2.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)

10.1.2.3.3 Rest Of South & Central America: Microcarriers Market, by Product

10.1.2.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment

10.1.2.3.5 Rest of South & Central America: Microcarriers Market, by Application

10.1.2.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production

10.1.2.3.6 Rest Of South & Central America: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

11.1 Overview

11.2 Organic Growth Strategies

11.2.1 Overview

11.3 Inorganic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Bio-Rad Laboratories Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Sartorius AG

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Danaher Corp

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Eppendorf SE

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Asahi Kasei Corp

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Polysciences Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Microcarriers Market Segmentation

Table 2. Brazil Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)

Table 3. Brazil Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)

Table 4. Brazil Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)

Table 5. Brazil Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)

Table 6. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User

Table 7. Argentina Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)

Table 8. Argentina Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)

Table 9. Argentina Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)

Table 10. Argentina Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)

Table 11. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User

Table 12. Rest Of South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)

Table 13. Rest Of South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)

Table 14. Rest Of South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)

Table 15. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)

Table 16. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User

Table 17. Recent Organic Growth Strategies in Microcarriers Market

Table 18. Recent Inorganic Growth Strategies in the Microcarriers Market

Table 19. Glossary of Terms

List of Figures

Figure 1. Microcarriers Market Segmentation, By Country

Figure 2. Key Insights

Figure 3. Microcarriers Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market

Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030

Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)

Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)

Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)

Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. South & Central America Microcarriers Market Share by End User - 2022 & 2030 (%)

Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)

Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)

Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)

Figure 24. Microcarriers Market, 2022 (US$Mn)

Figure 25. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)

Figure 26. Brazil: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)

1. Bio-Rad Laboratories Inc

2. Sartorius AG

3. Danaher Corp

4. Eppendorf SE

5. Asahi Kasei Corp

6. Polysciences Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America microcarriers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America microcarriers market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440